Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold) and Lilly (Silver).

The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ASCO 2016 | Key tips for using Twitter for hematologists

Michael Thompson • 3 Jun 2016
ASCO 2016
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Hodgkin Lymphoma Mantle Cell Lymphoma Multiple Myeloma Non-Hodgkin Lymphoma

Michael Thompson, MD, PhD of the Aurora Health Care, Milwaukee, WI shares some key Twitter tips for hematologists. Some of the tips Dr Thompson gives include staying authentic, deciding on what kind of presence you would like to establish and providing full disclosure on any potential conflicts of interest. Dr Thompson also mentions that Twitter may not be right for everyone and suggests other formats such as blogging.
Recorded at the American Society of Oncology (ASCO) 2016 Annual Meeting held in Chicago, IL.

Explore the AML Channel banner with headshots of Naval Daver, Eunice Wang, and Thomas Cluzeau

More from Michael Thompson

Engaging healthcare professionals and patients with social media
3:28
Engaging healthcare professionals and patients with social media
Michael Thompson • 4 Apr 2016
Why hematologists should use social media
2:10
Why hematologists should use social media
Michael Thompson • 3 Jun 2016
Quality over quantity - a look at the ASH and ASCO social media networks
2:24
Quality over quantity - a look at the ASH and ASCO social media networks
Michael Thompson • 3 Jun 2016

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals